Alumis Appoints Sapna Srivastava, Ph.D., to its Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Alumis, a precision immunology company incubated by Foresite Labs that is reimagining the discovery, development and treatment of autoimmune disorders, today announced the appointment of Sapna Srivastava, Ph.D., a biotechnology and financial industry leader, to its board of directors. “We are pleased to welcome Sapna to...

Click to view original post